Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Letrozole|DRUG: Ribociclib|DRUG: Placebo
Sponsor: Qamar Khan
Collaborators: Novartis Pharmaceuticals